MedTrace Logo

Direct Current Neuromuscular Electrical Stimulation for Treatment of Peripheral Neuropathy

NCT05442021 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2023-05-25

No results posted yet for this study

Summary

This study will compare two methods of electrical stimulation (alternating current and direct current) as an adjunctive therapy to treating peripheral neuropathy. Both types of electrical stimulation have been used in clinical practice for physical therapy, however direct current stimulation is much less common and there is less known about their impact on physical therapy outcomes. The aim of this project is to show the efficacy of a novel device, the Neubie direct current device, compared to traditional TENS unit, in clinical physical therapy treatment of neuropathy. Outcomes measured will include three methods of two-point discrimination, vibration sense, pain, and score on the modified Toronto Clinical Neuropathy scale.

Conditions

Interventions

DEVICE

Neubie Direct Current Electrical Stimulation Device

Direct Current Electrical Stimulation Device that uses electrodes non-invasively on the skin to stimulate muscle fibers.

DEVICE

TENS

Transcutaneous Electrical Nerve Stimulation device - uses alternating current delivered through electrodes on the skin.

Sponsors & Collaborators

  • NeuFit - Neurological Fitness and Education

    lead INDUSTRY

Principal Investigators

  • Ramona von Leden, PhD · NeuFit - Neurological Fitness and Education

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2023-05-20
Completion
2023-05-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05442021 on ClinicalTrials.gov